Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
114.49
-3.83 (-3.24%)
At close: Jul 31, 2026, 4:00 PM EDT
116.76
+2.27 (1.98%)
After-hours: Jul 31, 2026, 7:54 PM EDT

Corcept Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
111.04120.5127.67135.5566.3377.62
Short-Term Investments
197.16251.66255.67232.67365.34145.92
Cash & Short-Term Investments
308.2372.15383.33368.22431.67223.54
Cash Growth
-9.94%-2.92%4.10%-14.70%93.11%-49.28%
Accounts Receivable
76.9259.7953.9841.1231.0627.63
Other Receivables
---1414-
Total Trade Receivables
76.9259.7953.9855.1245.0627.63
Inventory
13.1912.8712.417.736.14.99
Other Current Assets
41.3740.6621.8827.5616.4210.32
Total Current Assets
439.68485.46471.6458.64499.25266.46
Net Property, Plant & Equipment
11.996.478.010.321.781.52
Long-Term Investments
236.45160.27219.8357.184.95112.28
Other Long-Term Assets
200.58184.44141.11105.3977.4543.5
Total Assets
888.7836.65840.55621.52583.43423.76
Accounts Payable
14.9140.4415.3817.411.986.91
Accrued Expenses
136.98124.56124.5786.9659.3740.11
Current Portion of Leases
1.921.080.830.151.140.53
Total Current Liabilities
153.8166.09140.77104.5172.4947.54
Long-Term Leases
7.55.026.11---
Other Long-Term Liabilities
21.6217.7414.0810.319.10.41
Total Long-Term Liabilities
29.1222.7620.1910.319.10.41
Total Liabilities
182.93188.85160.96114.8181.5947.95
Common Stock
0.140.140.140.130.130.13
Treasury Stock
-998.01-966.59-696.17-635.08-456.15-410.41
Additional Paid-in Capital
1,049968.6832.11738.52662.34591.35
Accumulated Other Comprehensive Income
0.442.26-0.220.61-0.87-0.23
Retained Earnings
654.61643.39543.74402.53296.39194.97
Shareholders' Equity
705.78647.81679.59506.71501.84375.81
Total Liabilities & Equity
888.7836.65840.55621.52583.43423.76
Total Debt
9.426.116.940.151.140.53
Net Cash (Debt)
298.78366.05376.4368.07430.53223.01
Net Cash Growth
-10.98%-2.75%2.26%-14.51%93.05%-49.10%
Net Cash Per Share
2.593.053.323.293.711.77
Book Value
705.78647.81679.59506.71501.84375.81
Book Value Per Share
6.115.405.994.534.332.98
Tangible Book Value
705.78647.81679.59506.71501.84375.81
Tangible Book Value Per Share
6.115.405.994.534.332.98
SEC Filings: 10-K · 10-Q